{"id":130434,"date":"2026-06-25T12:03:52","date_gmt":"2026-06-25T06:33:52","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=130434"},"modified":"2026-06-25T12:03:54","modified_gmt":"2026-06-25T06:33:54","slug":"divis-laboratories-q1-results-fy27","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/","title":{"rendered":"Divis Laboratories Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Divis Laboratories Q1 Results FY27: Uniresearch projects Revenue Rs 2,800 Cr | PAT Rs 643 Cr (30-analyst consensus). Q4 FY26: Rev Rs 2,831 Cr | PAT Rs 751 Cr.<\/em><\/p>\n<p>The <a href=\"https:\/\/univest.in\/stocks\/divislab\/divi's-laboratories-ltd-share-price-today\">Divis Laboratories<\/a> Q1 Results FY27 outlook is anchored on Q4 FY26 verified actuals and Uniresearch analysis applying the 30-analyst FY27 consensus to Q1 FY26 verified actuals. Uniresearch projects Revenue Rs 2,800 Cr (+16.2% YoY) and PAT Rs 643 Cr (+18.0% YoY). Prepared by Ankit Jaiswal.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=divis-laboratories-q1-results-fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#Divis_Laboratories_%E2%80%93_Uniresearch_Prediction\" title=\"Divis Laboratories &#8211; Uniresearch Prediction\">Divis Laboratories &#8211; Uniresearch Prediction<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#Divis_Laboratories_Q4_FY26_Key_Metrics_%E2%80%93_Baseline_for_Divis_Laboratories\" title=\"Divis Laboratories Q4 FY26 Key Metrics &#8211; Baseline for Divis Laboratories\">Divis Laboratories Q4 FY26 Key Metrics &#8211; Baseline for Divis Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#What_Analysts_Are_Saying_About_Divis_Laboratories\" title=\"What Analysts Are Saying About Divis Laboratories\">What Analysts Are Saying About Divis Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#Key_Watchpoints_for_Divis_Laboratories\" title=\"Key Watchpoints for Divis Laboratories\">Key Watchpoints for Divis Laboratories<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#Revenue_Delivery_vs_Consensus_in_Divis_Laboratories_Q1_Results_FY27\" title=\"Revenue Delivery vs Consensus in Divis Laboratories Q1 Results FY27\">Revenue Delivery vs Consensus in Divis Laboratories Q1 Results FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#PAT_Performance_in_Divis_Laboratories_Q1_Results_FY27\" title=\"PAT Performance in Divis Laboratories Q1 Results FY27\">PAT Performance in Divis Laboratories Q1 Results FY27<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#Risks_to_the_Divis_Laboratories_Prediction\" title=\"Risks to the Divis Laboratories Prediction\">Risks to the Divis Laboratories Prediction<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#Below-Consensus_Revenue_Growth_in_Divis_Laboratories_Q1_Results_FY27\" title=\"Below-Consensus Revenue Growth in Divis Laboratories Q1 Results FY27\">Below-Consensus Revenue Growth in Divis Laboratories Q1 Results FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#PAT_Pressure_in_Divis_Laboratories_Q1_Results_FY27\" title=\"PAT Pressure in Divis Laboratories Q1 Results FY27\">PAT Pressure in Divis Laboratories Q1 Results FY27<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#Conclusion_Divis_Laboratories\" title=\"Conclusion: Divis Laboratories\">Conclusion: Divis Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#Frequently_Asked_Questions_on_Divis_Laboratories\" title=\"Frequently Asked Questions on Divis Laboratories\">Frequently Asked Questions on Divis Laboratories<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#What_is_Uniresearchs_PAT_prediction_for_Divis_Laboratories_Q1_Results_FY27\" title=\"What is Uniresearch&#8217;s PAT prediction for Divis Laboratories Q1 Results FY27?\">What is Uniresearch&#8217;s PAT prediction for Divis Laboratories Q1 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#What_is_the_Revenue_prediction_for_Divis_Laboratories_Q1_Results_FY27\" title=\"What is the Revenue prediction for Divis Laboratories Q1 Results FY27?\">What is the Revenue prediction for Divis Laboratories Q1 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#What_were_Divis_Laboratories_Q1_Results_FY27\" title=\"What were Divis Laboratories Q1 Results FY27?\">What were Divis Laboratories Q1 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#Does_the_Divis_Laboratories_Q1_Results_FY27_article_contain_Univest_estimates\" title=\"Does the Divis Laboratories Q1 Results FY27 article contain Univest estimates?\">Does the Divis Laboratories Q1 Results FY27 article contain Univest estimates?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#What_is_the_analyst_target_price_in_the_Divis_Laboratories_Q1_Results_FY27_article\" title=\"What is the analyst target price in the Divis Laboratories Q1 Results FY27 article?\">What is the analyst target price in the Divis Laboratories Q1 Results FY27 article?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#What_are_the_risks_to_the_Divis_Laboratories_Q1_Results_FY27_prediction\" title=\"What are the risks to the Divis Laboratories Q1 Results FY27 prediction?\">What are the risks to the Divis Laboratories Q1 Results FY27 prediction?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/divis-laboratories-q1-results-fy27\/#What_is_the_Q1_FY26_base_for_the_Divis_Laboratories_Q1_Results_FY27_prediction\" title=\"What is the Q1 FY26 base for the Divis Laboratories Q1 Results FY27 prediction?\">What is the Q1 FY26 base for the Divis Laboratories Q1 Results FY27 prediction?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Divis_Laboratories_%E2%80%93_Uniresearch_Prediction\"><\/span><strong>Divis Laboratories &#8211; Uniresearch Prediction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px; margin: 16px 0;\">\n<tbody>\n<tr>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Metric<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Q1 FY26 Actual<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Q1 Results FY27 Uniresearch Prediction<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>YoY Change<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Source<\/strong><\/th>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi's-laboratories-ltd-share-price-today\">Divis Laboratories<\/a> Revenue (Rs Cr)<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">2,410<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">2,800<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">+16.2%<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Uniresearch | 30-analyst consensus applied to Q1 FY26 verified actual<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">PAT (Rs Cr)<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">545<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">643<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">+18.0%<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Uniresearch | 30-analyst consensus applied to Q1 FY26 verified actual<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Avg Analyst Target<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Rs 7,066<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">12-month view<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">&#8211;<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Analyst consensus (30 analysts)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"font-size: 12px; color: #666;\"><em>Predictions apply 30-analyst FY27 consensus (Rev +16.2%, PAT +18.0%) to Q1 FY26 verified actuals. Not guaranteed outcomes.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Divis_Laboratories_Q4_FY26_Key_Metrics_%E2%80%93_Baseline_for_Divis_Laboratories\"><\/span><strong>Divis Laboratories Q4 FY26 Key Metrics &#8211; Baseline for Divis Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px; margin: 16px 0;\">\n<tbody>\n<tr>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Metric<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Q4 FY26 Actual<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>YoY Change<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Source<\/strong><\/th>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Revenue (Rs Cr)<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">2,831<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">+9.5% YoY<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Consolidated quarterly financial data<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">PAT (Rs Cr)<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">751<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">+13.4% YoY<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Consolidated quarterly financial data<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"What_Analysts_Are_Saying_About_Divis_Laboratories\"><\/span><strong>What Analysts Are Saying About Divis Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Across 30 analysts covering Divis Laboratories, the FY27 consensus projects revenue growth of +16.2% and profit growth of +18.0%, with an average 12-month price target of Rs 7,066. The Q1 Results FY27 prediction of Rs 643 Cr PAT and Rs 2,800 Cr Revenue reflects this consensus applied to verified Q1 FY26 actuals.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Watchpoints_for_Divis_Laboratories\"><\/span><strong>Key Watchpoints for Divis Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Delivery_vs_Consensus_in_Divis_Laboratories_Q1_Results_FY27\"><\/span><strong>Revenue Delivery vs Consensus in Divis Laboratories Q1 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The primary watchpoint is whether Q1 Results FY27 Revenue delivers in line with Uniresearch projection of Rs 2,800 Cr (based on the 30-analyst consensus growth of +16.2%). Q1 FY26 base was Rs 2,410 Cr.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"PAT_Performance_in_Divis_Laboratories_Q1_Results_FY27\"><\/span><strong>PAT Performance in Divis Laboratories Q1 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Q1 Results FY27 PAT watchpoint is whether Divis Laboratories achieves Rs 643 Cr as projected (consensus PAT growth: +18.0% from Q1 FY26 base of Rs 545 Cr). Q4 FY26 PAT was Rs 751 Cr.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_the_Divis_Laboratories_Prediction\"><\/span><strong>Risks to the Divis Laboratories Prediction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Below-Consensus_Revenue_Growth_in_Divis_Laboratories_Q1_Results_FY27\"><\/span><strong>Below-Consensus Revenue Growth in Divis Laboratories Q1 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>If Q1 Results FY27 revenue comes in below the +16.2% consensus, actual revenue would fall short of Rs 2,800 Cr. Sector-specific demand conditions are the primary variable.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"PAT_Pressure_in_Divis_Laboratories_Q1_Results_FY27\"><\/span><strong>PAT Pressure in Divis Laboratories Q1 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The PAT prediction of Rs 643 Cr could be impacted by cost escalation or one-time charges not factored into the 30-analyst consensus of +18.0%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_Divis_Laboratories\"><\/span><strong>Conclusion: Divis Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Divis Laboratories Uniresearch prediction of Revenue Rs 2,800 Cr and PAT Rs 643 Cr is derived from the 30-analyst consensus FY27 growth rates applied to verified Q1 FY26 actuals. No assumptions by Univest. When Q1 Results FY27 are declared, investors can benchmark actual performance against this consensus prediction. Track live updates on Univest.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Track Divis Laboratories Live on the Univest Screener<\/strong><\/a><\/p>\n<p><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> for live Q1 Results FY27 alerts.<\/em><\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions are derived by applying analyst consensus growth rates to verified Q1 FY26 actuals &#8211; these are analyst consensus projections and are not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Divis_Laboratories\"><\/span><strong>Frequently Asked Questions on Divis Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Uniresearchs_PAT_prediction_for_Divis_Laboratories_Q1_Results_FY27\"><\/span><strong>What is Uniresearch&#8217;s PAT prediction for Divis Laboratories Q1 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Uniresearch projects Divis Laboratories PAT at Rs 643 Cr, applying 30-analyst FY27 profit growth consensus of +18.0% to Q1 FY26 verified PAT of Rs 545 Cr.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Revenue_prediction_for_Divis_Laboratories_Q1_Results_FY27\"><\/span><strong>What is the Revenue prediction for Divis Laboratories Q1 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divis Laboratories Revenue is projected at Rs 2,800 Cr by Uniresearch, applying +16.2% FY27 revenue consensus to verified Q1 FY26 base.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_Divis_Laboratories_Q1_Results_FY27\"><\/span><strong>What were Divis Laboratories Q1 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Q4 FY26 consolidated Revenue was Rs 2,831 Cr (+9.5% YoY) and PAT was Rs 751 Cr (+13.4% YoY) per consolidated financial data.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_the_Divis_Laboratories_Q1_Results_FY27_article_contain_Univest_estimates\"><\/span><strong>Does the Divis Laboratories Q1 Results FY27 article contain Univest estimates?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. All Divis Laboratories predictions are derived from the 30-analyst consensus applied to verified Q1 FY26 actuals.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_analyst_target_price_in_the_Divis_Laboratories_Q1_Results_FY27_article\"><\/span><strong>What is the analyst target price in the Divis Laboratories Q1 Results FY27 article?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 30-analyst consensus gives an average 12-month price target of Rs 7,066 for Divis Laboratories per the Q1 Results FY27 prediction basis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_to_the_Divis_Laboratories_Q1_Results_FY27_prediction\"><\/span><strong>What are the risks to the Divis Laboratories Q1 Results FY27 prediction?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Risks include below-consensus revenue growth (target: +16.2%) and PAT pressure from unexpected costs impacting the +18.0% PAT consensus.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Q1_FY26_base_for_the_Divis_Laboratories_Q1_Results_FY27_prediction\"><\/span><strong>What is the Q1 FY26 base for the Divis Laboratories Q1 Results FY27 prediction?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Q1 FY26 consolidated Revenue was Rs 2,410 Cr and PAT was Rs 545 Cr. These verified actuals form the base for the Divis Laboratories prediction.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Divis Laboratories Q1 Results FY27: Uniresearch projects Q1 Results FY27 Revenue Rs 2,800 Cr and PAT Rs 643 Cr (30-analyst consensus). Q4 FY26 actuals, analyst views and watchpoints inside.<\/p>\n","protected":false},"author":34,"featured_media":130799,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-130434","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1782369238:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["82"],"rank_math_title":["Divis Laboratories Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints"],"rank_math_description":["Divis Laboratories Q1 Results FY27: Uniresearch projects Q1 Results FY27 Revenue Rs 2,800 Cr and PAT Rs 643 Cr (30-analyst consensus). Q4 FY26 actuals, analyst views and watchpoints inside."],"rank_math_focus_keyword":["Divis Laboratories Q1 Results"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["130799"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["21171"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Divis-Laboratories-Q1-Results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/130434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=130434"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/130434\/revisions"}],"predecessor-version":[{"id":130800,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/130434\/revisions\/130800"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/130799"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=130434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=130434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=130434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}